Nov
11
AACE Issues New Medical Guidelines For Proper & Ethical Use Of Growth Hormone (HGH)
November 11, 2009 | Leave a Comment
The American Association of Clinical Endocrinologists (AACE) released new medical guidelines for the accurate diagnosis and effective ethical treatment of growth hormone deficiency in affected patients.
“Although there is not a wealth of medical data published concerning HGH as a recovery tool for injured athletes, it’s certainly not an approved indication for use,” Dr. David Cook, Interim Division Chief of Endocrinology at the Oregon Health & Science University, and co-author of the new medical guidelines said. “These guidelines are the result of recent advancements in our understanding of the benefits of growth hormone replacement for patients,” Dr. Cook said.
Responsiveness to growth hormone therapy is often determined by many variables, such as age, sex, adiposity, and concurrent medications. However, even after accounting for these variables, there remain highly individual differences in the response to growth hormone. “Controlled trials, using strict dosing regimes and measuring clinical end points, such as body composition and insulin sensitivity, have shown us that growth hormone (HGH)Â dosing should be individualized, with close attention to avoiding side effects,” Dr. Cook said.
Want to read more about what a doctor has to say about HGH? Click here.
Read the entire AACE/HGH article
Apr
21
AACE Discusses Medical Tattooing
April 21, 2009 | Leave a Comment
AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone (hgh)Â deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated - particularly in the case of hypoglycemic coma. However, it also poses some health concerns - ones that the study’s primary author,
Saleh Aldasouqi, MD, FACE, feels the medical community may need to weigh in on. “Like it or not, tattooing for purposes of medical alerts is a phenomenon that is now occurring,” Dr. Aldasouqi said. “It’s imperative that the medical community take note and that, perhaps, appropriate regulation of the practice be proposed, especially for patients with diabetes.”
Read the entire AACE/Medical Tattoo/HGH story here.
Apr
3
AACE & HGH
April 3, 2009 | Leave a Comment
WASHINGTON,
Related to these efforts is the American Association of Clinical Endocrinologists (AACE): AACE is a professional medical organization with more than 6,200 members in
the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE clinical endocrinologists advanced, specialized training enable them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For further information about AACE, visit www.aace.com.
Read more about HGH and what a doctor recommends to her patients by clicking here.
Recommended Links
GET YOUR FREE HGH &
ANTI-AGING REPORT!
- Get your own FREE copy of the groundbreaking report, "Seven Age Reversing Secrets" – packed with valuable tips and tricks to help you fight the aging process and have the highest quality of life possible!